Page last updated: 2024-09-04

rhodioloside and Osteogenic Sarcoma

rhodioloside has been researched along with Osteogenic Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Huang, L; Huang, Z; Lin, W; Lv, C; Wang, L; Yang, S; Zhu, X	1

Other Studies

1 other study(ies) available for rhodioloside and Osteogenic Sarcoma

Article	Year
Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway. International journal of oncology, 2019, Volume: 54, Issue:6 Topics: Antineoplastic Agents; Bone Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Janus Kinase 2; Osteosarcoma; Phenols; Signal Transduction; STAT3 Transcription Factor	2019

Article

Year

Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway.

International journal of oncology, 2019, Volume: 54, Issue:6

Topics: Antineoplastic Agents; Bone Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Janus Kinase 2; Osteosarcoma; Phenols; Signal Transduction; STAT3 Transcription Factor

2019